rs6495306
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000745.4(CHRNA5):c.107-7260G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.643 in 152,054 control chromosomes in the GnomAD database, including 31,900 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.64 ( 31900 hom., cov: 32)
Consequence
CHRNA5
NM_000745.4 intron
NM_000745.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.52
Publications
37 publications found
Genes affected
CHRNA5 (HGNC:1959): (cholinergic receptor nicotinic alpha 5 subunit) The protein encoded by this gene is a nicotinic acetylcholine receptor subunit and a member of a superfamily of ligand-gated ion channels that mediate fast signal transmission at synapses. These receptors are thought to be heteropentamers composed of separate but similar subunits. Defects in this gene have been linked to susceptibility to lung cancer type 2 (LNCR2).[provided by RefSeq, Jun 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.799 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.643 AC: 97693AN: 151936Hom.: 31850 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
97693
AN:
151936
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.643 AC: 97805AN: 152054Hom.: 31900 Cov.: 32 AF XY: 0.648 AC XY: 48142AN XY: 74330 show subpopulations
GnomAD4 genome
AF:
AC:
97805
AN:
152054
Hom.:
Cov.:
32
AF XY:
AC XY:
48142
AN XY:
74330
show subpopulations
African (AFR)
AF:
AC:
28826
AN:
41468
American (AMR)
AF:
AC:
11378
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
2158
AN:
3468
East Asian (EAS)
AF:
AC:
4243
AN:
5174
South Asian (SAS)
AF:
AC:
3235
AN:
4824
European-Finnish (FIN)
AF:
AC:
6603
AN:
10566
Middle Eastern (MID)
AF:
AC:
227
AN:
294
European-Non Finnish (NFE)
AF:
AC:
39202
AN:
67964
Other (OTH)
AF:
AC:
1416
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1759
3519
5278
7038
8797
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
782
1564
2346
3128
3910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.